
================================================================================
Q: Which diseases and traits are associated with the genes TP53 and KRAS?
[TOOL SELECTION PROMPT] You are an assistant deciding which tools to use to answer a biomedical question. User question: """Which diseases and traits are associated with the genes TP53 and KRAS?""" 

 If the question mentioned a database or tool and we do not have it, use the most similar available one. Available tools: - extract_entities: Extracts genes and all biomedical entities from the user question for query understanding using both Claude and GLiNER models. Returns genes (Claude + GLiNER), traits, and all entity types found by GLiNER. This tool MUST be called first before running any other tool as it provides essential entity extraction for pipeline execution.
- expand_gene_set_by_trait: Use this tool ONLY IF the expanded gene set by a trait is REQUIRED to answer the question. This could be used to discover more relevant genes underlying a trait, if a broader genetic context would be valuable for the analysis. Searches for genetic associations with diseases, traits, or phenotypes mentioned in the user query and expands the gene list with additional related genes found through GWAS associations. 
- gencode_gene_node: Annotates genes with GENCODE gene annotations such as transcripts, number exons, genomic span. Essential for many downstream analyses.
- humanbase_functions: Fetch per-gene functional predictions from HumanBase tissue-specific networks. Provides expanded list of functions.
- uniprot_base: Queries UniProt for functional annotations and disease links.
- query_gwas_by_gene: Retrieves genome-wide association study (GWAS) results for a given gene. It collects traits and diseases associated with genetic variants linked to that gene, along with the specific variants
- query_gwas_extensive: This is a more comprehensive version of the query_gwas_by_gene tool, and it is used to retrieve more detailed information about the GWAS results. It collects an extensive list of traits/diseases associated with an extensive list of genetic variants linked to that gene. Use this tool *ONLY* if the question is very specific that requires what is equivalent to an extensive database search, not to general characterisation of the gene.
- uniprot_gwas: Runs UniProt query again on genes identified via GWAS associations. Helps to expand the base annotations with related genes.
- BioGRID: Fetches gene interactions from BioGRID and their functional annotations for the input genes. Provides a curated context-specific list of protein-protein, genetic and chemical interactions.
- reactome: Fetches Reactome pathways associated with the input genes. Provides a curated collection of biological pathways which describe how molecules interact within a cell to carry out different biological processes.
- Summarize_bioGRID_GO: Required for BioGrid. Summarizes BioGRID GO terms for the input genes. Provides a compact list of GO terms for the input genes.
- variant_annotations: Fetches dbSNP data about the identified variants. This requires gwas to be run first. This is to be used only when the variant needs to be annotated with its **coordinates** and **chromosome number** and similar details. This tool is also a prerequisite to run humanbase, sei, alphamissense, etc. Reason based on the user's question if sequence models need to be run, and if so, this tool is a prerequisite to run them.
- variant_population_summaries: Fetches population-wide summaries of allele frequencies for the identified variants across studies. Useful for characterizing the frequency of variants in the population. This requires gwas to be run first.
- sei: Fetches predictions of the sequence regulatory activity for given variants. This requires variant_annotations to be run first.
- humanbase_expecto: Fetches Expecto, gene expression disruption predictions from HumanBase per variant. Pulls all precomputed predictions for the input genes.
- humanbase_tissue_expecto_annotate_variants: Annotates variants with tissue-specific expression disruption predictions from HumanBase. Requires humanbase_expecto and variant_annotations to be run first.
- alphamissense: Fetches Alphamissense predicted pathogenicity classes for given variants. This requires variant_annotations to be run first.
- miRDB: Fetches miRDB computationally predicted gene targets of miRNA..

 Examples workflows: EXAMPLE PIPELINES (pay attention to dependencies):

1. Variant regulatory activity (e.g. SEI):
   extract_entities → query_gwas_by_gene → variant_annotations → sei

2. Variant pathogenicity (e.g. AlphaMissense):
   extract_entities → query_gwas_by_gene → variant_annotations → alphamissense

3. HumanBase Expecto variant annotation:
   extract_entities → humanbase_expecto → query_gwas_by_gene → variant_annotations → humanbase_tissue_expecto_annotate_variants

4. Gene-level functional annotation:
   extract_entities → gencode_gene_node → (humanbase_functions, uniprot_base, reactome, BioGRID) → Summarize_bioGRID_GO (if BioGRID run) → uniprot_gwas (if gwas run)

Note these are only examples, and in real life you may need to run combinations of these tools depending on the user intent and the entities extracted.

 
 Which tools should be called, and in what order? Respond *ONLY* with a Python list of tool names. Example: ["humanbase_functions", "uniprot_base"] or ["humanbase_functions", "uniprot_base", "query_gwas_by_gene"] or ["query_gwas_by_gene", "BioGRID"]
[TOOL SELECTION RESPONSE] Message(id='msg_01TAPyrZUfaZt8Mx9da2UTcm', content=[TextBlock(citations=None, text='["extract_entities", "query_gwas_by_gene", "uniprot_base"]', type='text')], model='claude-sonnet-4-20250514', role='assistant', stop_reason='end_turn', stop_sequence=None, type='message', usage=Usage(cache_creation_input_tokens=0, cache_read_input_tokens=0, input_tokens=1323, output_tokens=25, server_tool_use=None, service_tier='standard', cache_creation={'ephemeral_5m_input_tokens': 0, 'ephemeral_1h_input_tokens': 0}))
[TOOL INVOKE] Selected tools: ['extract_entities', 'query_gwas_by_gene', 'uniprot_base']
[TOOL INVOKE] Already used tools: []
[TOOL RUN] → extract_entities
[_extract_entities_with_claude] Found: {'genes': ['TP53', 'KRAS'], 'traits': []}
[_get_flair_model] Loaded FLAIR model: hunflair2
[_extract_entities_with_flair] Found: {'genes': [], 'proteins': [], 'traits': []}
[_get_gliner_model] Loaded GLiNER model: urchade/gliner_medium-v2.1
[_extract_entities_with_gliner] Found: {'genes': ['TP53', 'KRAS'], 'proteins': [], 'traits': []}
[_extract_rsids] Found: []
[_extract_chr_allele_pos] Found: []
[_extract_ensembl_ids] Found: {'genes': [], 'proteins': [], 'transcripts': []}
[_extract_entities_with_regex] Found entities: {'variants': {}, 'chr_pos_variants': {}, 'ensembl_genes': [], 'ensembl_proteins': [], 'ensembl_transcripts': []}
[_extract_entities_merged] Final Merged Genes: ['TP53', 'KRAS']
[_extract_entities_merged] Final Merged Traits: []
[_extract_entities_merged] Final Merged Proteins: []
[_extract_entities_merged] Final Merged Transcripts: []
[_extract_entities_merged] Final Merged Variants: {}
[entity_extraction_node] Extracted: {'genes': ['TP53', 'KRAS'], 'traits': [], 'proteins': [], 'transcripts': [], 'variants': {}, 'chr_pos_variants': {}}
[TOOL RUN] → query_gwas_by_gene
[GWAS] Querying associations for gene: TP53
[GWAS] Querying associations for gene: TP53 in summary mode
[GWAS] TP53: found, 239 total associations, 235 significant, 72 studies, 0 variant annotations
[GWAS] Querying associations for gene: KRAS
[GWAS] Querying associations for gene: KRAS in summary mode
[GWAS] KRAS: found, 4 total associations, 3 significant, 3 studies, 0 variant annotations
[TOOL RUN] → uniprot_base
Fetching UniProt entries for 2 genes: ['TP53', 'KRAS']
Fetching UniProt entry for gene: TP53
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck', 'function': 'Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2', 'go_terms': "C:PML body, C:centrosome, C:chromatin, C:cytoplasm, C:cytosol, C:endoplasmic reticulum, C:germ cell nucleus, C:mitochondrial matrix, C:mitochondrion, C:nuclear matrix, C:nucleolus, C:nucleoplasm, C:nucleus, C:protein-containing complex, C:replication fork, C:site of double-strand break, C:transcription regulator complex, C:transcription repressor complex, F:14-3-3 protein binding, F:ATP-dependent DNA/DNA annealing activity, F:DNA binding, F:DNA-binding transcription activator activity, RNA polymerase II-specific, F:DNA-binding transcription factor activity, F:DNA-binding transcription factor activity, RNA polymerase II-specific, F:DNA-binding transcription repressor activity, RNA polymerase II-specific, F:MDM2/MDM4 family protein binding, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, F:RNA polymerase II-specific DNA-binding transcription factor binding, F:TFIID-class transcription factor complex binding, F:chromatin binding, F:cis-regulatory region sequence-specific DNA binding, F:copper ion binding, F:core promoter sequence-specific DNA binding, F:disordered domain specific binding, F:enzyme binding, F:general transcription initiation factor binding, F:histone deacetylase binding, F:histone deacetylase regulator activity, F:identical protein binding, F:mRNA 3'-UTR binding, F:molecular condensate scaffold activity, F:molecular function activator activity, F:p53 binding, F:promoter-specific chromatin binding, F:protease binding, F:protein heterodimerization activity, F:protein phosphatase 2A binding, F:protein-folding chaperone binding, F:receptor tyrosine kinase binding, F:transcription cis-regulatory region binding, F:transcription coactivator binding, F:ubiquitin protein ligase binding, F:zinc ion binding, P:B cell lineage commitment, P:DNA damage response, P:DNA damage response, signal transduction by p53 class mediator, P:ER overload response, P:Ras protein signal transduction, P:T cell differentiation in thymus, P:T cell lineage commitment, P:T cell proliferation involved in immune response, P:autophagy, P:bone marrow development, P:cardiac muscle cell apoptotic process, P:cardiac septum morphogenesis, P:cellular response to UV, P:cellular response to UV-C, P:cellular response to actinomycin D, P:cellular response to gamma radiation, P:cellular response to glucose starvation, P:cellular response to hypoxia, P:cellular response to ionizing radiation, P:cellular response to xenobiotic stimulus, P:cellular senescence, P:cerebellum development, P:chromosome organization, P:circadian behavior, P:determination of adult lifespan, P:double-strand break repair, P:embryonic organ development, P:entrainment of circadian clock by photoperiod, P:fibroblast proliferation, P:gastrulation, P:glial cell proliferation, P:glucose catabolic process to lactate via pyruvate, P:hematopoietic progenitor cell differentiation, P:hematopoietic stem cell differentiation, P:in utero embryonic development, P:intrinsic apoptotic signaling pathway, P:intrinsic apoptotic signaling pathway by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, P:intrinsic apoptotic signaling pathway in response to hypoxia, P:mRNA transcription, P:mitochondrial DNA repair, P:mitophagy, P:mitotic G1 DNA damage checkpoint signaling, P:multicellular organism growth, P:necroptotic process, P:negative regulation of DNA replication, P:negative regulation of DNA-templated transcription, P:negative regulation of G1 to G0 transition, P:negative regulation of apoptotic process, P:negative regulation of cell growth, P:negative regulation of cell population proliferation, P:negative regulation of fibroblast proliferation, P:negative regulation of glial cell proliferation, P:negative regulation of glucose catabolic process to lactate via pyruvate, P:negative regulation of helicase activity, P:negative regulation of miRNA processing, P:negative regulation of mitophagy, P:negative regulation of neuroblast proliferation, P:negative regulation of pentose-phosphate shunt, P:negative regulation of proteolysis, P:negative regulation of reactive oxygen species metabolic process, P:negative regulation of stem cell proliferation, P:negative regulation of telomere maintenance via telomerase, P:negative regulation of transcription by RNA polymerase II, P:negative regulation of transforming growth factor beta receptor signaling pathway, P:neuroblast proliferation, P:neuron apoptotic process, P:nucleotide-excision repair, P:oligodendrocyte apoptotic process, P:oxidative stress-induced premature senescence, P:positive regulation of DNA-templated transcription, P:positive regulation of RNA polymerase II transcription preinitiation complex assembly, P:positive regulation of apoptotic process, P:positive regulation of cardiac muscle cell apoptotic process, P:positive regulation of cellular senescence, P:positive regulation of execution phase of apoptosis, P:positive regulation of gene expression, P:positive regulation of intrinsic apoptotic signaling pathway, P:positive regulation of miRNA transcription, P:positive regulation of mitochondrial membrane permeability, P:positive regulation of neuron apoptotic process, P:positive regulation of programmed necrotic cell death, P:positive regulation of reactive oxygen species metabolic process, P:positive regulation of release of cytochrome c from mitochondria, P:positive regulation of thymocyte apoptotic process, P:positive regulation of transcription by RNA polymerase II, P:protein import into nucleus, P:protein localization, P:protein stabilization, P:protein tetramerization, P:protein-containing complex assembly, P:rRNA transcription, P:reactive oxygen species metabolic process, P:regulation of DNA damage response, signal transduction by p53 class mediator, P:regulation of DNA-templated transcription, P:regulation of apoptotic process, P:regulation of cell cycle, P:regulation of cell cycle G2/M phase transition, P:regulation of fibroblast apoptotic process, P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator, P:regulation of mitochondrial membrane permeability involved in apoptotic process, P:regulation of tissue remodeling, P:regulation of transcription by RNA polymerase II, P:release of cytochrome c from mitochondria, P:replicative senescence, P:response to X-ray, P:response to antibiotic, P:response to gamma radiation, P:response to ischemia, P:response to salt stress, P:signal transduction by p53 class mediator, P:somitogenesis, P:stem cell proliferation, P:thymocyte apoptotic process, P:transcription initiation-coupled chromatin remodeling, P:transforming growth factor beta receptor signaling pathway, P:tumor necrosis factor-mediated signaling pathway, P:type II interferon-mediated signaling pathway, P:viral process"}
Fetching UniProt entry for gene: TP53
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck', 'function': 'Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2', 'go_terms': "C:PML body, C:centrosome, C:chromatin, C:cytoplasm, C:cytosol, C:endoplasmic reticulum, C:germ cell nucleus, C:mitochondrial matrix, C:mitochondrion, C:nuclear matrix, C:nucleolus, C:nucleoplasm, C:nucleus, C:protein-containing complex, C:replication fork, C:site of double-strand break, C:transcription regulator complex, C:transcription repressor complex, F:14-3-3 protein binding, F:ATP-dependent DNA/DNA annealing activity, F:DNA binding, F:DNA-binding transcription activator activity, RNA polymerase II-specific, F:DNA-binding transcription factor activity, F:DNA-binding transcription factor activity, RNA polymerase II-specific, F:DNA-binding transcription repressor activity, RNA polymerase II-specific, F:MDM2/MDM4 family protein binding, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, F:RNA polymerase II-specific DNA-binding transcription factor binding, F:TFIID-class transcription factor complex binding, F:chromatin binding, F:cis-regulatory region sequence-specific DNA binding, F:copper ion binding, F:core promoter sequence-specific DNA binding, F:disordered domain specific binding, F:enzyme binding, F:general transcription initiation factor binding, F:histone deacetylase binding, F:histone deacetylase regulator activity, F:identical protein binding, F:mRNA 3'-UTR binding, F:molecular condensate scaffold activity, F:molecular function activator activity, F:p53 binding, F:promoter-specific chromatin binding, F:protease binding, F:protein heterodimerization activity, F:protein phosphatase 2A binding, F:protein-folding chaperone binding, F:receptor tyrosine kinase binding, F:transcription cis-regulatory region binding, F:transcription coactivator binding, F:ubiquitin protein ligase binding, F:zinc ion binding, P:B cell lineage commitment, P:DNA damage response, P:DNA damage response, signal transduction by p53 class mediator, P:ER overload response, P:Ras protein signal transduction, P:T cell differentiation in thymus, P:T cell lineage commitment, P:T cell proliferation involved in immune response, P:autophagy, P:bone marrow development, P:cardiac muscle cell apoptotic process, P:cardiac septum morphogenesis, P:cellular response to UV, P:cellular response to UV-C, P:cellular response to actinomycin D, P:cellular response to gamma radiation, P:cellular response to glucose starvation, P:cellular response to hypoxia, P:cellular response to ionizing radiation, P:cellular response to xenobiotic stimulus, P:cellular senescence, P:cerebellum development, P:chromosome organization, P:circadian behavior, P:determination of adult lifespan, P:double-strand break repair, P:embryonic organ development, P:entrainment of circadian clock by photoperiod, P:fibroblast proliferation, P:gastrulation, P:glial cell proliferation, P:glucose catabolic process to lactate via pyruvate, P:hematopoietic progenitor cell differentiation, P:hematopoietic stem cell differentiation, P:in utero embryonic development, P:intrinsic apoptotic signaling pathway, P:intrinsic apoptotic signaling pathway by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, P:intrinsic apoptotic signaling pathway in response to hypoxia, P:mRNA transcription, P:mitochondrial DNA repair, P:mitophagy, P:mitotic G1 DNA damage checkpoint signaling, P:multicellular organism growth, P:necroptotic process, P:negative regulation of DNA replication, P:negative regulation of DNA-templated transcription, P:negative regulation of G1 to G0 transition, P:negative regulation of apoptotic process, P:negative regulation of cell growth, P:negative regulation of cell population proliferation, P:negative regulation of fibroblast proliferation, P:negative regulation of glial cell proliferation, P:negative regulation of glucose catabolic process to lactate via pyruvate, P:negative regulation of helicase activity, P:negative regulation of miRNA processing, P:negative regulation of mitophagy, P:negative regulation of neuroblast proliferation, P:negative regulation of pentose-phosphate shunt, P:negative regulation of proteolysis, P:negative regulation of reactive oxygen species metabolic process, P:negative regulation of stem cell proliferation, P:negative regulation of telomere maintenance via telomerase, P:negative regulation of transcription by RNA polymerase II, P:negative regulation of transforming growth factor beta receptor signaling pathway, P:neuroblast proliferation, P:neuron apoptotic process, P:nucleotide-excision repair, P:oligodendrocyte apoptotic process, P:oxidative stress-induced premature senescence, P:positive regulation of DNA-templated transcription, P:positive regulation of RNA polymerase II transcription preinitiation complex assembly, P:positive regulation of apoptotic process, P:positive regulation of cardiac muscle cell apoptotic process, P:positive regulation of cellular senescence, P:positive regulation of execution phase of apoptosis, P:positive regulation of gene expression, P:positive regulation of intrinsic apoptotic signaling pathway, P:positive regulation of miRNA transcription, P:positive regulation of mitochondrial membrane permeability, P:positive regulation of neuron apoptotic process, P:positive regulation of programmed necrotic cell death, P:positive regulation of reactive oxygen species metabolic process, P:positive regulation of release of cytochrome c from mitochondria, P:positive regulation of thymocyte apoptotic process, P:positive regulation of transcription by RNA polymerase II, P:protein import into nucleus, P:protein localization, P:protein stabilization, P:protein tetramerization, P:protein-containing complex assembly, P:rRNA transcription, P:reactive oxygen species metabolic process, P:regulation of DNA damage response, signal transduction by p53 class mediator, P:regulation of DNA-templated transcription, P:regulation of apoptotic process, P:regulation of cell cycle, P:regulation of cell cycle G2/M phase transition, P:regulation of fibroblast apoptotic process, P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator, P:regulation of mitochondrial membrane permeability involved in apoptotic process, P:regulation of tissue remodeling, P:regulation of transcription by RNA polymerase II, P:release of cytochrome c from mitochondria, P:replicative senescence, P:response to X-ray, P:response to antibiotic, P:response to gamma radiation, P:response to ischemia, P:response to salt stress, P:signal transduction by p53 class mediator, P:somitogenesis, P:stem cell proliferation, P:thymocyte apoptotic process, P:transcription initiation-coupled chromatin remodeling, P:transforming growth factor beta receptor signaling pathway, P:tumor necrosis factor-mediated signaling pathway, P:type II interferon-mediated signaling pathway, P:viral process"}
Fetching UniProt entry for gene: KRAS
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Cardiofaciocutaneous syndrome 2, Gastric cancer, Leukemia, acute myelogenous, Leukemia, juvenile myelomonocytic, Noonan syndrome 3, Oculoectodermal syndrome, Schimmelpenning-Feuerstein-Mims syndrome', 'function': 'Ras proteins bind GDP/GTP and possess intrinsic GTPase activity . Plays an important role in the regulation of cell proliferation . Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner', 'go_terms': 'C:Golgi membrane, C:cytoplasm, C:cytoplasmic side of plasma membrane, C:cytosol, C:endoplasmic reticulum membrane, C:focal adhesion, C:membrane, C:mitochondrial outer membrane, C:plasma membrane, F:G protein activity, F:GDP binding, F:GMP binding, F:GTP binding, F:GTPase activity, F:LRR domain binding, F:identical protein binding, F:protein-containing complex binding, F:protein-membrane adaptor activity, P:MAPK cascade, P:Rac protein signal transduction, P:Ras protein signal transduction, P:actin cytoskeleton organization, P:cardiac muscle cell proliferation, P:cytokine-mediated signaling pathway, P:epithelial tube branching involved in lung morphogenesis, P:female pregnancy, P:forebrain astrocyte development, P:gene expression, P:glial cell proliferation, P:homeostasis of number of cells within a tissue, P:liver development, P:myoblast proliferation, P:negative regulation of epithelial cell differentiation, P:negative regulation of neuron apoptotic process, P:neuron apoptotic process, P:positive regulation of Rac protein signal transduction, P:positive regulation of cellular senescence, P:positive regulation of gene expression, P:positive regulation of glial cell proliferation, P:regulation of long-term neuronal synaptic plasticity, P:regulation of synaptic transmission, GABAergic, P:response to glucocorticoid, P:response to gravity, P:response to isolation stress, P:response to mineralocorticoid, P:skeletal muscle cell differentiation, P:striated muscle cell differentiation, P:type I pneumocyte differentiation, P:visual learning'}
Fetching UniProt entry for gene: KRAS
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Cardiofaciocutaneous syndrome 2, Gastric cancer, Leukemia, acute myelogenous, Leukemia, juvenile myelomonocytic, Noonan syndrome 3, Oculoectodermal syndrome, Schimmelpenning-Feuerstein-Mims syndrome', 'function': 'Ras proteins bind GDP/GTP and possess intrinsic GTPase activity . Plays an important role in the regulation of cell proliferation . Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner', 'go_terms': 'C:Golgi membrane, C:cytoplasm, C:cytoplasmic side of plasma membrane, C:cytosol, C:endoplasmic reticulum membrane, C:focal adhesion, C:membrane, C:mitochondrial outer membrane, C:plasma membrane, F:G protein activity, F:GDP binding, F:GMP binding, F:GTP binding, F:GTPase activity, F:LRR domain binding, F:identical protein binding, F:protein-containing complex binding, F:protein-membrane adaptor activity, P:MAPK cascade, P:Rac protein signal transduction, P:Ras protein signal transduction, P:actin cytoskeleton organization, P:cardiac muscle cell proliferation, P:cytokine-mediated signaling pathway, P:epithelial tube branching involved in lung morphogenesis, P:female pregnancy, P:forebrain astrocyte development, P:gene expression, P:glial cell proliferation, P:homeostasis of number of cells within a tissue, P:liver development, P:myoblast proliferation, P:negative regulation of epithelial cell differentiation, P:negative regulation of neuron apoptotic process, P:neuron apoptotic process, P:positive regulation of Rac protein signal transduction, P:positive regulation of cellular senescence, P:positive regulation of gene expression, P:positive regulation of glial cell proliferation, P:regulation of long-term neuronal synaptic plasticity, P:regulation of synaptic transmission, GABAergic, P:response to glucocorticoid, P:response to gravity, P:response to isolation stress, P:response to mineralocorticoid, P:skeletal muscle cell differentiation, P:striated muscle cell differentiation, P:type I pneumocyte differentiation, P:visual learning'}
[TOOL SELECTION] Selecting additional tools based on current state.
[create_context_block function] preparing context block...
[create_context_block] genes to summarize: ['TP53', 'KRAS']
[TOOL SELECTION PROMPT] You are an assistant deciding which tools to use to answer a biomedical question. User question: """Which diseases and traits are associated with the genes TP53 and KRAS?""" 

 If the question mentioned a database or tool and we do not have it, use the most similar available one. Available tools: - extract_entities: Extracts genes and all biomedical entities from the user question for query understanding using both Claude and GLiNER models. Returns genes (Claude + GLiNER), traits, and all entity types found by GLiNER. This tool MUST be called first before running any other tool as it provides essential entity extraction for pipeline execution.
- expand_gene_set_by_trait: Use this tool ONLY IF the expanded gene set by a trait is REQUIRED to answer the question. This could be used to discover more relevant genes underlying a trait, if a broader genetic context would be valuable for the analysis. Searches for genetic associations with diseases, traits, or phenotypes mentioned in the user query and expands the gene list with additional related genes found through GWAS associations. 
- gencode_gene_node: Annotates genes with GENCODE gene annotations such as transcripts, number exons, genomic span. Essential for many downstream analyses.
- humanbase_functions: Fetch per-gene functional predictions from HumanBase tissue-specific networks. Provides expanded list of functions.
- uniprot_base: Queries UniProt for functional annotations and disease links.
- query_gwas_by_gene: Retrieves genome-wide association study (GWAS) results for a given gene. It collects traits and diseases associated with genetic variants linked to that gene, along with the specific variants
- query_gwas_extensive: This is a more comprehensive version of the query_gwas_by_gene tool, and it is used to retrieve more detailed information about the GWAS results. It collects an extensive list of traits/diseases associated with an extensive list of genetic variants linked to that gene. Use this tool *ONLY* if the question is very specific that requires what is equivalent to an extensive database search, not to general characterisation of the gene.
- uniprot_gwas: Runs UniProt query again on genes identified via GWAS associations. Helps to expand the base annotations with related genes.
- BioGRID: Fetches gene interactions from BioGRID and their functional annotations for the input genes. Provides a curated context-specific list of protein-protein, genetic and chemical interactions.
- reactome: Fetches Reactome pathways associated with the input genes. Provides a curated collection of biological pathways which describe how molecules interact within a cell to carry out different biological processes.
- Summarize_bioGRID_GO: Required for BioGrid. Summarizes BioGRID GO terms for the input genes. Provides a compact list of GO terms for the input genes.
- variant_annotations: Fetches dbSNP data about the identified variants. This requires gwas to be run first. This is to be used only when the variant needs to be annotated with its **coordinates** and **chromosome number** and similar details. This tool is also a prerequisite to run humanbase, sei, alphamissense, etc. Reason based on the user's question if sequence models need to be run, and if so, this tool is a prerequisite to run them.
- variant_population_summaries: Fetches population-wide summaries of allele frequencies for the identified variants across studies. Useful for characterizing the frequency of variants in the population. This requires gwas to be run first.
- sei: Fetches predictions of the sequence regulatory activity for given variants. This requires variant_annotations to be run first.
- humanbase_expecto: Fetches Expecto, gene expression disruption predictions from HumanBase per variant. Pulls all precomputed predictions for the input genes.
- humanbase_tissue_expecto_annotate_variants: Annotates variants with tissue-specific expression disruption predictions from HumanBase. Requires humanbase_expecto and variant_annotations to be run first.
- alphamissense: Fetches Alphamissense predicted pathogenicity classes for given variants. This requires variant_annotations to be run first.
- miRDB: Fetches miRDB computationally predicted gene targets of miRNA..

 Examples workflows: EXAMPLE PIPELINES (pay attention to dependencies):

1. Variant regulatory activity (e.g. SEI):
   extract_entities → query_gwas_by_gene → variant_annotations → sei

2. Variant pathogenicity (e.g. AlphaMissense):
   extract_entities → query_gwas_by_gene → variant_annotations → alphamissense

3. HumanBase Expecto variant annotation:
   extract_entities → humanbase_expecto → query_gwas_by_gene → variant_annotations → humanbase_tissue_expecto_annotate_variants

4. Gene-level functional annotation:
   extract_entities → gencode_gene_node → (humanbase_functions, uniprot_base, reactome, BioGRID) → Summarize_bioGRID_GO (if BioGRID run) → uniprot_gwas (if gwas run)

Note these are only examples, and in real life you may need to run combinations of these tools depending on the user intent and the entities extracted.

 
 Which tools should be called, and in what order? Respond *ONLY* with a Python list of tool names. Example: ["humanbase_functions", "uniprot_base"] or ["humanbase_functions", "uniprot_base", "query_gwas_by_gene"] or ["query_gwas_by_gene", "BioGRID"]

Already used tools: extract_entities, query_gwas_by_gene, uniprot_base
Do not repeat tools already used.
IMPORTANT: if no additional tools are needed, return [] with no explanation.
Overall, NO explanation, downatream parser can only work with a list of tools.

Current context block:
{gene: TP53, GWAS-based associations and their statistical significance for the gene and its variants, for example connection to traits, protein levels etc. Returns associations that are high-risk or high-signifiance or both.: {gene: TP53, found: true, total_associations: 239, total_significant_associations: 235, total_studies_analyzed: 72, summary_by_high_risk_alleles: {related_genes: [TP53], high_risk_snps: [rs17880847, rs28934576, rs78378222, rs74351250, rs572488097, rs201214141, rs17881850, rs1642792, rs62062585, rs138932666, rs78496430, rs17883687, rs1042522, rs55745760, rs1625895, rs8073498, rs17882854, rs2909430, rs4968204, rs9894946], affected_protein_levels: [AXL, EDA2R, FLT3LG, Non-albumin, SAT2, SHBG, Serum total, TNFSF13, TP53], associated_disease_traits: [Uterine fibroids, Sex hormone-binding globulin levels, Body fat percentage (adjusted for testosterone and SHBG), Glioblastoma (age-stratified), Glioma, Skin cancer, Colon polyp, Mean corpuscular hemoglobin, Pulse pressure, Red blood cell count, Weight, Actinic keratosis (PheCode 702.1), Height (maximum, inv-normal transformed), Basal metabolic rate (UKB data field 23105), Low density lipoprotein cholesterol levels, Non-albumin protein levels, Elevated prostate specific antigen [PSA] (PheCode 796), Benign neoplasm of brain and other parts of nervous system (PheCode 225), Aspartate aminotransferase levels, Diseases of sebaceous glands (PheCode 706)]}, summary_by_significance: {related_genes: [TP53, SHBG], high_risk_snps: [rs78378222], affected_protein_levels: [], associated_disease_traits: [ICD10 D25: Leiomyoma of uterus, Uterine leiomyomata, Appendicular lean mass, Basal cell carcinoma (MTAG), Uterine fibroids, Basal cell carcinoma, Whole body fat free mass (UKB data field 23101), Mosaic loss of chromosome Y (Y chromosome dosage)]}}, Uniprot-derived annotations for the given gene, diseases and functions:: {diseases: Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck, function: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2}, dbSNP variant annotations (genomic coordinates and allele frequencies from population studies): {rs78378222: {mapped_gene: TP53, context: 3_prime_UTR_variant, variant_category: other, associated_disease_trait: {ICD10 D25: Leiomyoma of uterus: {p_value: 2e-121, risk_score: 0.55}, Uterine leiomyomata: {p_value: 9e-86, risk_score: 0.51}, Appendicular lean mass: {p_value: 5e-56, risk_score: 0.138}, Uterine fibroids: {p_value: 7.000000000000001e-31, risk_score: 1.54}, Basal cell carcinoma: {p_value: 9.999999999999999e-33, risk_score: 1.6192}, Whole body fat free mass (UKB data field 23101): {p_value: 3e-32, risk_score: 0.0723926}, Mosaic loss of chromosome Y (Y chromosome dosage): {p_value: 3e-28, risk_score: 0.013}}}, rs201214141: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {SAT2 protein levels: {p_value: 1e-242, risk_score: 0.5994269}}}, rs1642792: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {TNFSF13 protein levels: {p_value: 5e-23, risk_score: 0.23940623}, Body fat percentage (adjusted for testosterone and SHBG): {p_value: 3e-09, risk_score: 0.57}}}, rs62062585: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {SHBG protein levels: {p_value: 2e-13, risk_score: 0.19066834}, Body fat percentage (adjusted for testosterone and SHBG): {p_value: 6e-09, risk_score: 0.57}}}, rs1042522: {mapped_gene: TP53, context: missense_variant, variant_category: coding, associated_disease_trait: {TP53 protein levels: {p_value: 6e-16, risk_score: 0.057622924}, Sex hormone-binding globulin levels: {p_value: 0.0, risk_score: 0.1868}, Testosterone levels: {p_value: 1e-117, risk_score: 0.0661}, Glycated hemoglobin levels: {p_value: 3e-18, risk_score: 0.0243}, Serum total protein levels: {p_value: 3e-11, risk_score: 0.019}, Non-albumin protein levels: {p_value: 4e-10, risk_score: 0.0178}, Apolipoprotein B levels: {p_value: 9e-11, risk_score: 0.0177}, Low density lipoprotein cholesterol levels: {p_value: 1e-10, risk_score: 0.0176}, Triglyceride levels: {p_value: 4e-10, risk_score: 0.0171}}}, rs2909430: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Testosterone levels (UKB data field 30850): {p_value: 9.000000000000001e-29, risk_score: 0.024749031}}}, rs9894946: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Standing height (UKB data field 50): {p_value: 1e-12, risk_score: 0.010429073}}}, rs17883687: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 4e-74, risk_score: 0.1936}, Testosterone levels: {p_value: 4e-15, risk_score: 0.0837}}}, rs1625895: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 4e-195, risk_score: 0.1107}, Testosterone levels: {p_value: 5.9999999999999996e-36, risk_score: 0.0467}, Glycated hemoglobin levels: {p_value: 3e-12, risk_score: 0.0254}, Total cholesterol levels: {p_value: 7e-10, risk_score: 0.0219}, Aspartate aminotransferase levels: {p_value: 5e-09, risk_score: 0.0208}}}, rs74351250: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 4e-22, risk_score: 2.99}, Non-albumin protein levels: {p_value: 2.0000000000000002e-23, risk_score: 0.0569}, Testosterone levels: {p_value: 1e-10, risk_score: 0.0369}, Total testosterone levels: {p_value: 2e-18, risk_score: 0.34}}}, rs8073498: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 8.000000000000001e-131, risk_score: 0.0624}, Testosterone levels: {p_value: 1.0000000000000001e-34, risk_score: 0.0315}}}, rs17882854: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Non-albumin protein levels: {p_value: 1e-14, risk_score: 0.0581}}}, rs28934576: {mapped_gene: TP53, context: missense_variant, variant_category: coding, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 1e-08, risk_score: 3.86}}}, rs572488097: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 3e-08, risk_score: 1.09}}}, rs17881850: {mapped_gene: TP53, context: 3_prime_UTR_variant, variant_category: other, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 3e-10, risk_score: 0.58}}}, rs138932666: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 2e-17, risk_score: 0.47}}}, rs78496430: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 2e-10, risk_score: 0.29}}}, rs55745760: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG) x sex interaction: {p_value: 7e-09, risk_score: 0.17}}}, rs4968204: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Glucose levels: {p_value: 8e-09, risk_score: 0.014}}}, rs17880847: {mapped_gene: TP53, context: 3_prime_UTR_variant, variant_category: other, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 5e-33, risk_score: 4.15}, Total testosterone levels: {p_value: 7.999999999999999e-26, risk_score: 0.8}}}}}
{_marker: end of entity TP53 description}
{gene: KRAS, GWAS-based associations and their statistical significance for the gene and its variants, for example connection to traits, protein levels etc. Returns associations that are high-risk or high-signifiance or both.: {gene: KRAS, found: true, total_associations: 4, total_significant_associations: 3, total_studies_analyzed: 3, summary_by_high_risk_alleles: {related_genes: [KRAS, KRAS - RNU4-67P], high_risk_snps: [rs61761075, rs61759623, rs12318598], affected_protein_levels: [], associated_disease_traits: [Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model), Sex hormone-binding globulin levels, Liver enzyme levels (gamma-glutamyl transferase)]}, summary_by_significance: {related_genes: [KRAS, KRAS - RNU4-67P], high_risk_snps: [rs12318598, rs61759623, rs61761075], affected_protein_levels: [], associated_disease_traits: [Liver enzyme levels (gamma-glutamyl transferase), Sex hormone-binding globulin levels, Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model)]}}, Uniprot-derived annotations for the given gene, diseases and functions:: {diseases: Cardiofaciocutaneous syndrome 2, Gastric cancer, Leukemia, acute myelogenous, Leukemia, juvenile myelomonocytic, Noonan syndrome 3, Oculoectodermal syndrome, Schimmelpenning-Feuerstein-Mims syndrome, function: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity . Plays an important role in the regulation of cell proliferation . Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner}, dbSNP variant annotations (genomic coordinates and allele frequencies from population studies): {rs61761075: {mapped_gene: KRAS, context: intron_variant, variant_category: intronic, associated_disease_trait: {Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model): {p_value: 3e-08, risk_score: 1.3}}}, rs61759623: {mapped_gene: KRAS, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 1e-15, risk_score: 0.0547}}}, rs12318598: {mapped_gene: KRAS - RNU4-67P, context: intergenic_variant, variant_category: intergenic, associated_disease_trait: {Liver enzyme levels (gamma-glutamyl transferase): {p_value: 4e-20, risk_score: 0.0083005}}}}}
{_marker: end of entity KRAS description}


[TOOL SELECTION RESPONSE] Message(id='msg_01GxVSZF9onHGi7QtUUdevXp', content=[TextBlock(citations=None, text='[]', type='text')], model='claude-sonnet-4-20250514', role='assistant', stop_reason='end_turn', stop_sequence=None, type='message', usage=Usage(cache_creation_input_tokens=0, cache_read_input_tokens=0, input_tokens=5533, output_tokens=4, server_tool_use=None, service_tier='standard', cache_creation={'ephemeral_5m_input_tokens': 0, 'ephemeral_1h_input_tokens': 0}))
[TOOL INVOKE] Selected tools: []
[TOOL INVOKE] Already used tools: ['extract_entities', 'query_gwas_by_gene', 'uniprot_base']
[create_context_block function] preparing context block...
[create_context_block] genes to summarize: ['TP53', 'KRAS']
[conditioned_claude_node] context length before truncation: 12214
[conditioned_claude_node] system message: You are a biology data analyst. Answer strictly with facts you can point to inside CONTEXT. Respond only with JSON with keys answer and evidence. Ensure proper JSON format. Produce raw json output. I don't want markdown. The 'evidence' field must always be a list of short strings, and always reference the entity to which you are referring. If the CONTEXT contains trait-based associations (query_type: 'trait_based'), focus on the genetic associations with the queried trait/disease, including related genes, variants, and their biological significance.
[conditioned_claude_node] user question: Which diseases and traits are associated with the genes TP53 and KRAS?
[conditioned_claude_node] context block length: 12214
[conditioned_claude_node] full context block: {gene: TP53, GWAS-based associations and their statistical significance for the gene and its variants, for example connection to traits, protein levels etc. Returns associations that are high-risk or high-signifiance or both.: {gene: TP53, found: true, total_associations: 239, total_significant_associations: 235, total_studies_analyzed: 72, summary_by_high_risk_alleles: {related_genes: [TP53], high_risk_snps: [rs17880847, rs28934576, rs78378222, rs74351250, rs572488097, rs201214141, rs17881850, rs1642792, rs62062585, rs138932666, rs78496430, rs17883687, rs1042522, rs55745760, rs1625895, rs8073498, rs17882854, rs2909430, rs4968204, rs9894946], affected_protein_levels: [AXL, EDA2R, FLT3LG, Non-albumin, SAT2, SHBG, Serum total, TNFSF13, TP53], associated_disease_traits: [Uterine fibroids, Sex hormone-binding globulin levels, Body fat percentage (adjusted for testosterone and SHBG), Glioblastoma (age-stratified), Glioma, Skin cancer, Colon polyp, Mean corpuscular hemoglobin, Pulse pressure, Red blood cell count, Weight, Actinic keratosis (PheCode 702.1), Height (maximum, inv-normal transformed), Basal metabolic rate (UKB data field 23105), Low density lipoprotein cholesterol levels, Non-albumin protein levels, Elevated prostate specific antigen [PSA] (PheCode 796), Benign neoplasm of brain and other parts of nervous system (PheCode 225), Aspartate aminotransferase levels, Diseases of sebaceous glands (PheCode 706)]}, summary_by_significance: {related_genes: [TP53, SHBG], high_risk_snps: [rs78378222], affected_protein_levels: [], associated_disease_traits: [ICD10 D25: Leiomyoma of uterus, Uterine leiomyomata, Appendicular lean mass, Basal cell carcinoma (MTAG), Uterine fibroids, Basal cell carcinoma, Whole body fat free mass (UKB data field 23101), Mosaic loss of chromosome Y (Y chromosome dosage)]}}, Uniprot-derived annotations for the given gene, diseases and functions:: {diseases: Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck, function: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2}, dbSNP variant annotations (genomic coordinates and allele frequencies from population studies): {rs78378222: {mapped_gene: TP53, context: 3_prime_UTR_variant, variant_category: other, associated_disease_trait: {ICD10 D25: Leiomyoma of uterus: {p_value: 2e-121, risk_score: 0.55}, Uterine leiomyomata: {p_value: 9e-86, risk_score: 0.51}, Appendicular lean mass: {p_value: 5e-56, risk_score: 0.138}, Uterine fibroids: {p_value: 7.000000000000001e-31, risk_score: 1.54}, Basal cell carcinoma: {p_value: 9.999999999999999e-33, risk_score: 1.6192}, Whole body fat free mass (UKB data field 23101): {p_value: 3e-32, risk_score: 0.0723926}, Mosaic loss of chromosome Y (Y chromosome dosage): {p_value: 3e-28, risk_score: 0.013}}}, rs201214141: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {SAT2 protein levels: {p_value: 1e-242, risk_score: 0.5994269}}}, rs1642792: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {TNFSF13 protein levels: {p_value: 5e-23, risk_score: 0.23940623}, Body fat percentage (adjusted for testosterone and SHBG): {p_value: 3e-09, risk_score: 0.57}}}, rs62062585: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {SHBG protein levels: {p_value: 2e-13, risk_score: 0.19066834}, Body fat percentage (adjusted for testosterone and SHBG): {p_value: 6e-09, risk_score: 0.57}}}, rs1042522: {mapped_gene: TP53, context: missense_variant, variant_category: coding, associated_disease_trait: {TP53 protein levels: {p_value: 6e-16, risk_score: 0.057622924}, Sex hormone-binding globulin levels: {p_value: 0.0, risk_score: 0.1868}, Testosterone levels: {p_value: 1e-117, risk_score: 0.0661}, Glycated hemoglobin levels: {p_value: 3e-18, risk_score: 0.0243}, Serum total protein levels: {p_value: 3e-11, risk_score: 0.019}, Non-albumin protein levels: {p_value: 4e-10, risk_score: 0.0178}, Apolipoprotein B levels: {p_value: 9e-11, risk_score: 0.0177}, Low density lipoprotein cholesterol levels: {p_value: 1e-10, risk_score: 0.0176}, Triglyceride levels: {p_value: 4e-10, risk_score: 0.0171}}}, rs2909430: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Testosterone levels (UKB data field 30850): {p_value: 9.000000000000001e-29, risk_score: 0.024749031}}}, rs9894946: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Standing height (UKB data field 50): {p_value: 1e-12, risk_score: 0.010429073}}}, rs17883687: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 4e-74, risk_score: 0.1936}, Testosterone levels: {p_value: 4e-15, risk_score: 0.0837}}}, rs1625895: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 4e-195, risk_score: 0.1107}, Testosterone levels: {p_value: 5.9999999999999996e-36, risk_score: 0.0467}, Glycated hemoglobin levels: {p_value: 3e-12, risk_score: 0.0254}, Total cholesterol levels: {p_value: 7e-10, risk_score: 0.0219}, Aspartate aminotransferase levels: {p_value: 5e-09, risk_score: 0.0208}}}, rs74351250: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 4e-22, risk_score: 2.99}, Non-albumin protein levels: {p_value: 2.0000000000000002e-23, risk_score: 0.0569}, Testosterone levels: {p_value: 1e-10, risk_score: 0.0369}, Total testosterone levels: {p_value: 2e-18, risk_score: 0.34}}}, rs8073498: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 8.000000000000001e-131, risk_score: 0.0624}, Testosterone levels: {p_value: 1.0000000000000001e-34, risk_score: 0.0315}}}, rs17882854: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Non-albumin protein levels: {p_value: 1e-14, risk_score: 0.0581}}}, rs28934576: {mapped_gene: TP53, context: missense_variant, variant_category: coding, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 1e-08, risk_score: 3.86}}}, rs572488097: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 3e-08, risk_score: 1.09}}}, rs17881850: {mapped_gene: TP53, context: 3_prime_UTR_variant, variant_category: other, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 3e-10, risk_score: 0.58}}}, rs138932666: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 2e-17, risk_score: 0.47}}}, rs78496430: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG): {p_value: 2e-10, risk_score: 0.29}}}, rs55745760: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Body fat percentage (adjusted for testosterone and SHBG) x sex interaction: {p_value: 7e-09, risk_score: 0.17}}}, rs4968204: {mapped_gene: TP53, context: intron_variant, variant_category: intronic, associated_disease_trait: {Glucose levels: {p_value: 8e-09, risk_score: 0.014}}}, rs17880847: {mapped_gene: TP53, context: 3_prime_UTR_variant, variant_category: other, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 5e-33, risk_score: 4.15}, Total testosterone levels: {p_value: 7.999999999999999e-26, risk_score: 0.8}}}}}
{_marker: end of entity TP53 description}
{gene: KRAS, GWAS-based associations and their statistical significance for the gene and its variants, for example connection to traits, protein levels etc. Returns associations that are high-risk or high-signifiance or both.: {gene: KRAS, found: true, total_associations: 4, total_significant_associations: 3, total_studies_analyzed: 3, summary_by_high_risk_alleles: {related_genes: [KRAS, KRAS - RNU4-67P], high_risk_snps: [rs61761075, rs61759623, rs12318598], affected_protein_levels: [], associated_disease_traits: [Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model), Sex hormone-binding globulin levels, Liver enzyme levels (gamma-glutamyl transferase)]}, summary_by_significance: {related_genes: [KRAS, KRAS - RNU4-67P], high_risk_snps: [rs12318598, rs61759623, rs61761075], affected_protein_levels: [], associated_disease_traits: [Liver enzyme levels (gamma-glutamyl transferase), Sex hormone-binding globulin levels, Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model)]}}, Uniprot-derived annotations for the given gene, diseases and functions:: {diseases: Cardiofaciocutaneous syndrome 2, Gastric cancer, Leukemia, acute myelogenous, Leukemia, juvenile myelomonocytic, Noonan syndrome 3, Oculoectodermal syndrome, Schimmelpenning-Feuerstein-Mims syndrome, function: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity . Plays an important role in the regulation of cell proliferation . Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner}, dbSNP variant annotations (genomic coordinates and allele frequencies from population studies): {rs61761075: {mapped_gene: KRAS, context: intron_variant, variant_category: intronic, associated_disease_trait: {Tanner 3 to Tanner 4 pubertal stage transition (joint longitudinal BMI and survival model): {p_value: 3e-08, risk_score: 1.3}}}, rs61759623: {mapped_gene: KRAS, context: intron_variant, variant_category: intronic, associated_disease_trait: {Sex hormone-binding globulin levels: {p_value: 1e-15, risk_score: 0.0547}}}, rs12318598: {mapped_gene: KRAS - RNU4-67P, context: intergenic_variant, variant_category: intergenic, associated_disease_trait: {Liver enzyme levels (gamma-glutamyl transferase): {p_value: 4e-20, risk_score: 0.0083005}}}}}
{_marker: end of entity KRAS description}
[conditioned_claude_node] raw response from Claude: Message(id='msg_018GyrsR32E9VQXmNqsgShLt', content=[TextBlock(citations=None, text='{\n  "answer": "TP53 is associated with multiple cancers including basal cell carcinoma, glioblastoma, glioma, skin cancer, colon polyp, Li-Fraumeni syndrome, lung cancer, esophageal cancer, and squamous cell carcinoma of the head and neck. It is also associated with uterine fibroids, hormone-related traits (sex hormone-binding globulin levels, testosterone levels), metabolic traits (body fat percentage, cholesterol levels, glucose levels), and blood-related parameters (hemoglobin levels, red blood cell count). KRAS is associated with various cancers including gastric cancer and leukemias, developmental syndromes (Cardiofaciocutaneous syndrome 2, Noonan syndrome 3), and metabolic traits including liver enzyme levels and sex hormone-binding globulin levels.",\n  "evidence": [\n    "TP53 associated_disease_traits include Basal cell carcinoma, Glioblastoma, Glioma, Skin cancer, Colon polyp, Uterine fibroids",\n    "TP53 Uniprot diseases include Li-Fraumeni syndrome, Lung cancer, Esophageal cancer, Basal cell carcinoma 7, Squamous cell carcinoma of the head and neck",\n    "TP53 variants associated with Sex hormone-binding globulin levels, Testosterone levels, Body fat percentage, Low density lipoprotein cholesterol levels, Glucose levels",\n    "TP53 variants associated with Mean corpuscular hemoglobin, Red blood cell count, Glycated hemoglobin levels",\n    "KRAS Uniprot diseases include Gastric cancer, Leukemia acute myelogenous, Leukemia juvenile myelomonocytic, Cardiofaciocutaneous syndrome 2, Noonan syndrome 3",\n    "KRAS associated_disease_traits include Liver enzyme levels (gamma-glutamyl transferase), Sex hormone-binding globulin levels",\n    "KRAS variants associated with pubertal stage transition and metabolic parameters"\n  ]\n}', type='text')], model='claude-sonnet-4-20250514', role='assistant', stop_reason='end_turn', stop_sequence=None, type='message', usage=Usage(cache_creation_input_tokens=0, cache_read_input_tokens=0, input_tokens=4288, output_tokens=504, server_tool_use=None, service_tier='standard', cache_creation={'ephemeral_5m_input_tokens': 0, 'ephemeral_1h_input_tokens': 0}))
[conditioned_claude_node] processed response text: {
  "answer": "TP53 is associated with multiple cancers including basal cell carcinoma, glioblastoma, glioma, skin cancer, colon polyp, Li-Fraumeni syndrome, lung cancer, esophageal cancer, and squamous cell carcinoma of the head and neck. It is also associated with uterine fibroids, hormone-related traits (sex hormone-binding globulin levels, testosterone levels), metabolic traits (body fat percentage, cholesterol levels, glucose levels), and blood-related parameters (hemoglobin levels, red blood cell count). KRAS is associated with various cancers including gastric cancer and leukemias, developmental syndromes (Cardiofaciocutaneous syndrome 2, Noonan syndrome 3), and metabolic traits including liver enzyme levels and sex hormone-binding globulin levels.",
  "evidence": [
    "TP53 associated_disease_traits include Basal cell carcinoma, Glioblastoma, Glioma, Skin cancer, Colon polyp, Uterine fibroids",
    "TP53 Uniprot diseases include Li-Fraumeni syndrome, Lung cancer, Esophageal cancer, Basal cell carcinoma 7, Squamous cell carcinoma of the head and neck",
    "TP53 variants associated with Sex hormone-binding globulin levels, Testosterone levels, Body fat percentage, Low density lipoprotein cholesterol levels, Glucose levels",
    "TP53 variants associated with Mean corpuscular hemoglobin, Red blood cell count, Glycated hemoglobin levels",
    "KRAS Uniprot diseases include Gastric cancer, Leukemia acute myelogenous, Leukemia juvenile myelomonocytic, Cardiofaciocutaneous syndrome 2, Noonan syndrome 3",
    "KRAS associated_disease_traits include Liver enzyme levels (gamma-glutamyl transferase), Sex hormone-binding globulin levels",
    "KRAS variants associated with pubertal stage transition and metabolic parameters"
  ]
}
[verify_evidence_node] preparing verification...
[verify_evidence_node] pass 
('{\n'
 '  "answer": "TP53 is associated with multiple cancers including basal cell '
 'carcinoma, glioblastoma, glioma, skin cancer, colon polyp, Li-Fraumeni '
 'syndrome, lung cancer, esophageal cancer, and squamous cell carcinoma of the '
 'head and neck. It is also associated with uterine fibroids, hormone-related '
 'traits (sex hormone-binding globulin levels, testosterone levels), metabolic '
 'traits (body fat percentage, cholesterol levels, glucose levels), and '
 'blood-related parameters (hemoglobin levels, red blood cell count). KRAS is '
 'associated with various cancers including gastric cancer and leukemias, '
 'developmental syndromes (Cardiofaciocutaneous syndrome 2, Noonan syndrome '
 '3), and metabolic traits including liver enzyme levels and sex '
 'hormone-binding globulin levels.",\n'
 '  "evidence": [\n'
 '    "TP53 associated_disease_traits include Basal cell carcinoma, '
 'Glioblastoma, Glioma, Skin cancer, Colon polyp, Uterine fibroids",\n'
 '    "TP53 Uniprot diseases include Li-Fraumeni syndrome, Lung cancer, '
 'Esophageal cancer, Basal cell carcinoma 7, Squamous cell carcinoma of the '
 'head and neck",\n'
 '    "TP53 variants associated with Sex hormone-binding globulin levels, '
 'Testosterone levels, Body fat percentage, Low density lipoprotein '
 'cholesterol levels, Glucose levels",\n'
 '    "TP53 variants associated with Mean corpuscular hemoglobin, Red blood '
 'cell count, Glycated hemoglobin levels",\n'
 '    "KRAS Uniprot diseases include Gastric cancer, Leukemia acute '
 'myelogenous, Leukemia juvenile myelomonocytic, Cardiofaciocutaneous syndrome '
 '2, Noonan syndrome 3",\n'
 '    "KRAS associated_disease_traits include Liver enzyme levels '
 '(gamma-glutamyl transferase), Sex hormone-binding globulin levels",\n'
 '    "KRAS variants associated with pubertal stage transition and metabolic '
 'parameters"\n'
 '  ]\n'
 '}')
{'answer': 'TP53 is associated with multiple cancers including basal cell '
           'carcinoma, glioblastoma, glioma, skin cancer, colon polyp, '
           'Li-Fraumeni syndrome, lung cancer, esophageal cancer, and squamous '
           'cell carcinoma of the head and neck. It is also associated with '
           'uterine fibroids, hormone-related traits (sex hormone-binding '
           'globulin levels, testosterone levels), metabolic traits (body fat '
           'percentage, cholesterol levels, glucose levels), and blood-related '
           'parameters (hemoglobin levels, red blood cell count). KRAS is '
           'associated with various cancers including gastric cancer and '
           'leukemias, developmental syndromes (Cardiofaciocutaneous syndrome '
           '2, Noonan syndrome 3), and metabolic traits including liver enzyme '
           'levels and sex hormone-binding globulin levels.',
 'evidence': ['TP53 associated_disease_traits include Basal cell carcinoma, '
              'Glioblastoma, Glioma, Skin cancer, Colon polyp, Uterine '
              'fibroids',
              'TP53 Uniprot diseases include Li-Fraumeni syndrome, Lung '
              'cancer, Esophageal cancer, Basal cell carcinoma 7, Squamous '
              'cell carcinoma of the head and neck',
              'TP53 variants associated with Sex hormone-binding globulin '
              'levels, Testosterone levels, Body fat percentage, Low density '
              'lipoprotein cholesterol levels, Glucose levels',
              'TP53 variants associated with Mean corpuscular hemoglobin, Red '
              'blood cell count, Glycated hemoglobin levels',
              'KRAS Uniprot diseases include Gastric cancer, Leukemia acute '
              'myelogenous, Leukemia juvenile myelomonocytic, '
              'Cardiofaciocutaneous syndrome 2, Noonan syndrome 3',
              'KRAS associated_disease_traits include Liver enzyme levels '
              '(gamma-glutamyl transferase), Sex hormone-binding globulin '
              'levels',
              'KRAS variants associated with pubertal stage transition and '
              'metabolic parameters']}
